Let's Talk Laterally
We are One Lowenstein.
Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.
Experience
We represent clients across a wide range of industries. Please click on any of the practice links below to see a representative list of matters and clients.
- Private Equity / M&A
- Investment Management Funds
- Capital Markets
- Life Sciences
- Bankruptcy
- Litigation
- Emerging Companies & Venture Capital
- Intellectual Property
- Artificial Intelligence
- Crypto
$700,000,000
Represented Crown Laboratories in its merger agreement with
Revance Therapeutics, Inc. (NASDAQ: RVNC)
Represented Catalyst Investors and portfolio company, RepTrak Holdings, Inc. in the recapitalization and acquisition of The RepTrack Company by Periscope Equity LLC
Represented the KPS Global LLC management team in KPS Global’s sale from D Cubed Group to Viessmann Generations Group.
$250,000,000
Represented FalconPoint Partners in its investment in JENNMAR
$400,000,000
Represented Riddell, Inc. in its investment by BC Partners Credit
Represented Abry Partners in the PowerFleet, Inc. (NASDAQ: PWFL) and MiX Telematics Limited business combination
$750,000,000
Represented Hildred Capital Management in raising capital for its continuation fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
$58,000,000
Represented Digital Onboarding in the growth capital investment from Volition Capital
$66,809,220
Represented Hildred Capital Management in its acquisition of Hello Bello
Represented Avenues Global Holdings, LLC in its sale of Avenues New York and Avenues São Paulo to Nord Anglia Education
Represented Cerity Partners in its merger with Lumina Financial Consultants, LLC
Represented Cerity Partners in its merger with A&J Wealth Strategies LLC
Represented Founder and Executive Chair Anne Mahlum in the sale of her [solidcore] equity to Kohlberg & Co.
$110,000,000
Represented Consensus Sales in its $110 million investment by Sumeru Equity Partners
Represented Traub Capital Partners in its investment in Sabatino Tartufi
Represented LifeLabs Learning in its sale to Atairos
Represented New Mountain Capital portfolio company ILC Dover, Inc. in the sale of its Flood Pro division to PS Industries Incorporated
$250,000,000
Represented Evergreen Theragnostics, Inc. in its sale to Lantheus Medical Imaging, Inc.
$201,753,000
Represented Kintara Therapeutics, Inc. (Nasdaq: KTRA) in its definitive merger agreement with TuHURA Biosciences, Inc.
$1,330,000,000
Represented Chatham Asset Management, LLC, in its LBO acquisition of businesses from Vericast Corp. through R.R. Donnelley & Sons Company
$70,000,000
Represented Cyabra Strategy Ltd. In signing a definitivemerger agreement with special purpose acquisition vehicle (SPAC), Trailblazer Merger Corporation I
$1,700,000,000
Represented The Estee Lauder Companies Inc. (NYSE: EL) in its acquisition of DECIEM Beauty Group Inc.
$97,300,000
Represented Applied Digital
Corporation (NASDAQ: APLD) in
the sale of its Garden City, TX
Bitcoin mining data center
to Marathon Digital Holdings
$104,000,000
Represented
First Wave BioPharma, Inc.
(NASDAQ: FWBI) in its
acquisition of ImmunogenX
$169,000,000
Private Placement
Represented
Durable Capital Partners LP
Investor Counsel
$450,000,000
Convertible Notes
Private Offering
Represented NASDAQ: APLD
Issuer
Convertible Notes
Registered Direct Offering
Represented H.C. Wainwright & Co.
Placement Agent
$50,000,000
At-the-Market Offering
Represented NASDAQ: GANX
Issuer
At-the-Market Offering
Represented ROTH Capital Partners, LLC
Placement Agent
$75,000,000
At-the-Market Offering
Represented RBC Capital
Markets, LLC and BTIG, LLC
Sales Agents
At-the-Market Offering
Represented H.C. Wainwright & Co.
Placement Agent
Private Placement Offering
Represented NASDAQ: CING
Issuer
Underwritten Public Offering
Represented Special Situations Funds
Lead Investor
$100,000,000
Private Placement
Represented Piper Sandler (NYSE:PIPR)
Issuer
$460,500,000
Public Offering
Represented NASDAQ: CLDX
Issuer
$300,000,000
At-the-Market Offering
Represented NASDAQ: CLDX
Issuer
$94,500,000
Underwritten Public Offering
Represented NASDAQ: CRBP
Issuer
$100,000,000
Private Placement
Represented Piper Sandler
(NYSE: PIPR)
Issuer
$460,500,000
Public Offering
Represented NASDAQ: CLDX
Issuer
$150,000,000
At-the-Market Offering
Represented NASDAQ: CRBP
Issuer
$94,500,000
Underwritten Public Offering
Represented NASDAQ:CRBP
Issuer
$300,000,000
At-the-Market Offering
Represented NASDAQ: CLDX
Issuer
$26,500,000
Private Placement
Represented NASDAQ: COYA
Issuer
$924,000,000
Represented Crown Laboratories
in its merger agreement with
evance Therapeutics, Inc.
(NASDAQ: RVNC)
$750,000,000
Represented Hildred Capital Management in raising capital for its continuation fund, extending its ownership of Crown Laboratories and Hyland’s Naturals
$104,000,000
Represented
First Wave BioPharma, Inc.
(NASDAQ: FWBI) in its
acquisition of ImmunogenX
Represented Twill, Inc. in its
sale to DarioHealth Corp.
(NASDAQ: DRIO)
$66,809,220
Represented
Hildred Capital Management
in its acquisition of Hello Bello
Represented PicnicHealth in its acquisition of Allstripes
Represented Coya Therapeutics (NASDAQ: COYA) in a development-and-license deal with Dr. Reddy’s Laboratories for its COYA 302 drug
Represented
First Wave BioPharma, Inc.
(NASDAQ: FWBI) in its agreement
to license Capeserod from Sanofi
(NASDAQ: SNY)
$692,500,000
Represented Corbus Pharmaceuticals Holding Corp.(NASDAQ: CRBP) in its agreement to license CRB-701 from CSPC Megalith Biopharmaceutical Co., Ltd
Represented Tonix
Pharmaceuticals Holding Corp.
(NASDAQ: TNXP) in its licensing
of TNX-3600 and TNX-4100
from Columbia University
Represented Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) in its acquisition of Dr. Reddy's Laboratories’ license of E7777 from Eisai, Co., Ltd.
Represented Provention Bio, Inc. in an exclusive out-licensing of a novel potential treatment or cure for Hepatitis B Virus (HBV) to Enochian Biosciences, Inc.
Counsel to Official Committee of
Unsecured Creditors
Counsel to Debtor
Counsel to Official Committee of
Unsecured Creditors
Bankruptcy Counsel to
Defrauded Investors
Counsel to Official Committee of
Unsecured Creditors
Counsel to Official Committee of
Tort Claimant Creditors
Counsel to Official Committee of
Unsecured Creditors
Bankruptcy Counsel to
Defrauded Investors
Counsel to Official Committee of
Unsecured Creditors
Counsel to Official Committee of
Unsecured Creditors
Bankruptcy Counsel to
Defrauded Investors
Counsel to Official Committee of
Unsecured Creditors
Counsel to Debtor
Counsel to Official Committee of
Unsecured Creditors
Counsel to Official Committee of
Unsecured Creditors
Lead counsel to BASF in a $1B+ insurance matter seeking coverage for BASF’s alleged PFAS forever chemicals liabilities
Representing funds managed by Pentwater Capital Management in securities litigation alleging that Boeing, following two aviation disasters, misled investors on the timeline of the plane’s return to service schedule, resulting in significant damages
Representing Ørsted in their $300M dispute with the State of New Jersey over the cancellation of an offshore wind project
Won a lawsuit arising from a $186 million real estate transaction against an affiliate of the Kushner companies and prevailed on appeal challenging liquidated damages and legal fees
Argued before the Supreme Court of New Jersey and secured reversal of $24 million judgment against the Valley Hospital
*Represent investors in Perrigo
Helped secure, with co-counsel, a $97 million settlement for investors in a securities fraud class action against the pharmaceutical company Perrigo Co. plc.
$5,500,000
Series Seed
*Led by Extantia Capital
$50,000,000
Series B
$52,200,000
Series C
*Led by Oak HC/FT Partners
$12,000,000
Series A
$7,000,000
Series A
$265,000,000
Series E
$28,000,000
Series A
$40,000,000
Series B
$30,000,000
Series B
$75,000,000
Equity Financing
*Led by Cone Health Ventures & JPMorgan Chase’s Morgan Health.
$10,000,000
Series Seed
*Led by CRV
$75,000,000
Series B
$65,000,000
Series C
$45,000,000
Series B
* Led by Avidity Partners
$100,000,000
Series D
*Led by Spark Capital
$47,000,000
Series B
$80,000,000
Investment Financing
$46,000,000
Series B
*Led by First Round Capital and Andreessen Horowitz (a16z) Bio + Health
$55,000,000
Strategic Growth Investment
*Led by Vista Equity Partners
$6,000,000
Series A
*Led by Silas Capital
$15,000,000
Series A
*Led by Bessemer Venture Partners
$675,000,000
Series B
$30,000,000
Series C
*Led by Rockefeller Asset Management
$21,000,000
Investment
*Co-led by Healthier Capital and FirstMark Capital
$135,000,000
Series A
*Led by Sequoia, FTX Ventures &
Andreessen Horowitz
$3,500,000
Series Seed
$8,000,000
Series Seed
*Led by 6th Man Ventures
Represented Rainshine Global, Inc. in its strategic investment by Animoca Brands Japan, a subsidiary of Animoca Brands Corporation Limited.
Represented Floor NFTs in its
acquisition of WGMI.io
$8,000,000
Series A
*Led by Dragonfly Ventures III, L.P.
$7,000,000
Series Seed
$7,000,000
Series Seed
$35,000,000
Series C
$100,000,000
Series C
Represented Baxus
in its acquisition of BoozApp
$16,300,000
Series A
$130,000,000
Series B
$8,750,000
Investment
Contact Us
For more information, please contact us.
Patricia Cristadoro
Senior Manager of Lateral Recruiting